v3.26.3
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Jul. 31, 2026
Jul. 31, 2025
Revenue $ 2,100 $ 1,900
Cost of sales 760 760
Gross margin 1,340 1,140
Operating expenses:    
Research and development 906,629 997,206
Selling, general and administrative 2,033,801 878,053
Total operating expenses 2,940,430 1,875,259
Loss from operations (2,939,090) (1,874,119)
Other income (expense)    
Interest expense (235,261) (183,688)
Other income 2,007 2,813
Total other expense (233,254) (180,875)
Net loss $ (3,172,344) $ (2,054,994)
Net loss per share, basic and diluted (in dollars per share) $ (0.86) $ (1.58)
Weighted average common shares outstanding, basic and diluted (in shares) 3,668,945 1,303,532